FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Frederic Calon

Research Profile

Chemicals & Drugs

Disorders

Anatomy

Living Beings

Procedures

Autoradiography

Co-author Network

Publications

TOP 3
Isabelle St-Amour; Renée Bazin; Mélanie Bousquet; Francesca Cicchetti; Janelle Drouin-Ouellet; Isabelle Paré; Frederic Calon
Impact of intravenous immunoglobulin on the dopaminergic system and immune response in the acute MPTP mouse model of Parkinson's disease.
Cyril Bories; Yves De Koninck; Matthieu J Guitton; Carl Julien; Meriem Msaid; Cyntia Tremblay; Milène Vandal; Frederic Calon
Sex-dependent alterations in social behaviour and cortical synaptic activity coincide at different ages in a model of Alzheimer's disease.
Tuan Minh Do; Robert Farinotti; Marie-Sophie Noel-Hudson; Sandy Ribes; Jean-Michel Scherrmann; Maria Smirnova; Marion Buyse; Frederic Calon; Hélène Chacun; Giovanna Chimini; salvatore cisternino; Capucine Besengez; Fanchon Bourasset
ABCG2- and ABCG4-mediated efflux of amyloid-β peptide 1-40 at the mouse blood-brain barrier.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Frederic Calon (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Isabelle St-Amour; Renée Bazin; Mélanie Bousquet; Francesca Cicchetti; Janelle Drouin-Ouellet; Isabelle Paré; Frederic Calon
Impact of intravenous immunoglobulin on the dopaminergic system and immune response in the acute MPTP mouse model of Parkinson's disease.
Journal of neuroinflammation 2012;9():234.
2012: Cyril Bories; Yves De Koninck; Matthieu J Guitton; Carl Julien; Meriem Msaid; Cyntia Tremblay; Milène Vandal; Frederic Calon
Sex-dependent alterations in social behaviour and cortical synaptic activity coincide at different ages in a model of Alzheimer's disease.
PloS one 2012;7(9):e46111.
2012: Tuan Minh Do; Robert Farinotti; Marie-Sophie Noel-Hudson; Sandy Ribes; Jean-Michel Scherrmann; Maria Smirnova; Marion Buyse; Frederic Calon; Hélène Chacun; Giovanna Chimini; salvatore cisternino; Capucine Besengez; Fanchon Bourasset
ABCG2- and ABCG4-mediated efflux of amyloid-β peptide 1-40 at the mouse blood-brain barrier.
Journal of Alzheimer's disease : JAD 2012;30(1):155-66.
2012: Sarah Paris-Robidas; Mireille Pilote; Alex Rajput; Ali H Rajput; Marion Sintes; Cyntia Tremblay; Milène Vandal; Mélanie Bousquet; Elodie Brochu; Thérèse Di Paolo; Vincent Emond; Frederic Calon
Defective dentate nucleus GABA receptors in essential tremor.
Brain : a journal of neurology 2012;135(Pt 1):105-16.
2012: M Bousquet; Francesca Cicchetti; P Julien; I St-Amour; M Vandal; Frederic Calon
High-fat diet exacerbates MPTP-induced dopaminergic degeneration in mice.
Neurobiology of disease 2012;45(1):529-38.
2011: Tuan Minh Do; Robert Farinotti; Mélissa Ouellet; Frederic Calon; Hélène Chacun; Giovanna Chimini; Fanchon Bourasset
Direct evidence of abca1-mediated efflux of cholesterol at the mouse blood-brain barrier.
Molecular and cellular biochemistry 2011;357(1-2):397-404.
2011: Mélanie Bousquet; Frederic Calon; Francesca Cicchetti
Impact of ω-3 fatty acids in Parkinson's disease.
Ageing research reviews 2011;10(4):453-63.
2011: Sarah Paris-Robidas; Denis Soulet; Cyntia Tremblay; Vincent Emond; Frederic Calon
In vivo labeling of brain capillary endothelial cells after intravenous injection of monoclonal antibodies targeting the transferrin receptor.
Molecular pharmacology 2011;80(1):32-9.
2011: Melanie Bousquet; Karl Gue; Vincent Emond; Pierre Julien; Jing X Kang; Francesca Cicchetti; Frederic Calon
Transgenic conversion of omega-6 into omega-3 fatty acids in a mouse model of Parkinson's disease.
Journal of lipid research 2011;52(2):263-71.
2011: Janelle Drouin-Ouellet; Claire Gibrat; Jasna Kriz; Mélanie Bousquet; Frederic Calon; Francesca Cicchetti
The role of the MYD88-dependent pathway in MPTP-induced brain dopaminergic degeneration.
Journal of neuroinflammation 2011;8():137.
2010: Laura K Hamilton; Anne Aumont; Carl Julien; Alexandra Vadnais; Frederic Calon; Karl J L Fernandes
Widespread deficits in adult neurogenesis precede plaque and tangle formation in the 3xTg mouse model of Alzheimer's disease.
The European journal of neuroscience 2010;32(6):905-20.
2010: Mélanie Bousquet; Claire Gibrat; Mélissa Ouellet; Claude Rouillard; Frederic Calon; Francesca Cicchetti
Cystamine metabolism and brain transport properties: clinical implications for neurodegenerative diseases.
Journal of neurochemistry 2010;114(6):1651-8.
2010: Carl Julien; Cyntia Tremblay; Alix Phivilay; Line Berthiaume; Vincent Emond; Pierre Julien; Frederic Calon
High-fat diet aggravates amyloid-beta and tau pathologies in the 3xTg-AD mouse model.
Neurobiology of aging 2010;31(9):1516-31.
2010: Claire Gibrat; M Bousquet; Martine Saint-Pierre; Daniel Lévesque; Frederic Calon; Claude Rouillard; Francesca Cicchetti
Cystamine prevents MPTP-induced toxicity in young adult mice via the up-regulation of the brain-derived neurotrophic factor.
Progress in neuro-psychopharmacology & biological psychiatry 2010;34(1):193-203.
2009: Melissa Ouellet; Vincent Emond; Chuck T Chen; Carl Julien; Fanchon Bourasset; Salvatore Oddo; Frank M LaFerla; Richard P Bazinet; Frederic Calon
Diffusion of docosahexaenoic and eicosapentaenoic acids through the blood-brain barrier: An in situ cerebral perfusion study.
Neurochemistry international 2009;55(7):476-82.
2009: M Bousquet; Claire Gibrat; Martine Saint-Pierre; C Julien; Frederic Calon; Francesca Cicchetti
Modulation of brain-derived neurotrophic factor as a potential neuroprotective mechanism of action of omega-3 fatty acids in a parkinsonian animal model.
Progress in neuro-psychopharmacology & biological psychiatry 2009;33(8):1401-8.
2009: Pershia Samadi; Alex Rajput; Frederic Calon; Laurent Grégoire; Oleh Hornykiewicz; Ali H Rajput; Thérèse Di Paolo
Metabotropic glutamate receptor II in the brains of Parkinsonian patients.
Journal of neuropathology and experimental neurology 2009;68(4):374-82.
2009: A Phivilay; C Julien; C Tremblay; L Berthiaume; P Julien; Y Giguère; Frederic Calon
High dietary consumption of trans fatty acids decreases brain docosahexaenoic acid but does not alter amyloid-beta and tau pathologies in the 3xTg-AD model of Alzheimer's disease.
Neuroscience 2009;159(1):296-307.
2009: Fanchon Bourasset; Cyntia Tremblay; Carl Julien; Tuan Minh Do; Salvatore Oddo; Frank M LaFerla; Mélissa Ouellet; Frederic Calon
Reduction of the cerebrovascular volume in a transgenic mouse model of Alzheimer's disease.
Neuropharmacology 2009;56(4):808-13.
2009: Chuck T Chen; Zhen Liu; Melissa Ouellet; Frederic Calon; Richard P Bazinet
Rapid beta-oxidation of eicosapentaenoic acid in mouse brain: an in situ study.
Prostaglandins, leukotrienes, and essential fatty acids 2009;80(2-3):157-63.
2009: Carl Julien; Cyntia Tremblay; Vincent Emond; Meryem Lebbadi; Norman Salem; David A Bennett; Frederic Calon
Sirtuin 1 reduction parallels the accumulation of tau in Alzheimer disease.
Journal of neuropathology and experimental neurology 2009;68(1):48-58.
2008: Carl Julien; Cyntia Tremblay; Farid Bendjelloul; Alix Phivilay; Marie-Andrée Coulombe; Vincent Emond; Frederic Calon
Decreased drebrin mRNA expression in Alzheimer disease: correlation with tau pathology.
Journal of neuroscience research 2008;86(10):2292-302.
2008: Pershia Samadi; Laurent Grégoire; Marc Morissette; Frederic Calon; Abdallah Hadj Tahar; Mehdi Dridi; Nancy Belanger; Leonard T Meltzer; Paul J Bédard; Thérèse Di Paolo
mGluR5 metabotropic glutamate receptors and dyskinesias in MPTP monkeys.
Neurobiology of aging 2008;29(7):1040-51.
2008: qiulan ma; Fusheng Yang; Frederic Calon; Oliver J Ubeda; James E Hansen; Richard H Weisbart; Walter Beech; Sally A Frautschy; Gregory M. Cole
p21-activated kinase-aberrant activation and translocation in Alzheimer disease pathogenesis.
The Journal of biological chemistry 2008;283(20):14132-43.
2008: M Bousquet; M Saint-Pierre; C Julien; N Salem; F Cicchetti; Frederic Calon
Beneficial effects of dietary omega-3 polyunsaturated fatty acid on toxin-induced neuronal degeneration in an animal model of Parkinson's disease.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2008;22(4):1213-25.
2008: Pershia Samadi; Laurent Grégoire; Marc Morissette; Frederic Calon; Abdallah Hadj Tahar; Nancy Bélanger; Mehdi Dridi; Paul J Bédard; Thérèse Di Paolo
Basal ganglia group II metabotropic glutamate receptors specific binding in non-human primate model of L-Dopa-induced dyskinesias.
Neuropharmacology 2008;54(2):258-68.
2008: Pershia Samadi; Marc Morissette; Frederic Calon; Abdallah Hadj Tahar; Mehdi Dridi; Nancy Belanger; Leonard T Meltzer; Paul J Bédard; Thérèse Di Paolo
Normalization of GABAA receptor specific binding in the substantia nigra reticulata and the prevention of L-dopa-induced dyskinesias in MPTP parkinsonian monkeys.
Synapse (New York, N.Y.) 2008;62(2):101-9.
2008: Philippe Huot; Martin Lévesque; Marc Morissette; Frederic Calon; Mehdi Dridi; Thérèse Di Paolo; André Parent
L-Dopa treatment abolishes the numerical increase in striatal dopaminergic neurons in parkinsonian monkeys.
Journal of chemical neuroanatomy 2008;35(1):77-84.
2007: Cyntia Tremblay; Mireille Pilote; Alix Phivilay; Vincent Emond; David A Bennett; Frederic Calon
Biochemical characterization of Abeta and tau pathologies in mild cognitive impairment and Alzheimer's disease.
Journal of Alzheimer's disease : JAD 2007;12(4):377-90.
2007: Micaela Morelli; Therese Di Paolo; Jadwiga Wardas; Frederic Calon; Danqing Xiao; Michael A Schwarzschild
Role of adenosine A2A receptors in parkinsonian motor impairment and l-DOPA-induced motor complications.
Progress in neurobiology 2007;83(5):293-309.
2007: Frederic Calon; Gregory M. Cole
Neuroprotective action of omega-3 polyunsaturated fatty acids against neurodegenerative diseases: evidence from animal studies.
Prostaglandins, leukotrienes, and essential fatty acids 2007;77(5-6):287-93.
2007: Véronique Rivest; Alix Phivilay; Carl Julien; Sandra Bélanger; Cyntia Tremblay; Vincent Emond; Frederic Calon
Novel liposomal formulation for targeted gene delivery.
Pharmaceutical research 2007;24(5):981-90.
2006: Anthony H V Schapira; Erwan Bezard; Jonathan M Brotchie; Frederic Calon; Graham Collingridge; Boris Ferger; Bastian Hengerer; Etienne Hirsch; Peter Jenner; Nicolas Le Novère; Jose A Obeso; Michael A Schwarzschild; Umberto Spampinato; Giora Davidai
Novel pharmacological targets for the treatment of Parkinson's disease.
Nature reviews. Drug discovery 2006;5(10):845-54.
2006: Marc Morissette; Mehdi Dridi; Frederic Calon; Abdallah Hadj Tahar; Leonard T Meltzer; Paul J Bédard; Thérèse Di Paolo
Prevention of dyskinesia by an NMDA receptor antagonist in MPTP monkeys: effect on adenosine A2A receptors.
Synapse (New York, N.Y.) 2006;60(3):239-50.
2006: Carl Julien; Line Berthiaume; Abdallah Hadj Tahar; Ali H Rajput; Paul J Bédard; Thérèse Di Paolo; Pierre Julien; Frederic Calon
Postmortem brain fatty acid profile of levodopa-treated Parkinson disease patients and parkinsonian monkeys.
Neurochemistry international 2006;48(5):404-14.
2006: Frederic Calon
Nonpatentable drugs and the cost of our ignorance.
CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 2006;174(4):483-4.
2006: Lixia Zhao; qiulan ma; Frederic Calon; Marni E Harris-White; Fusheng Yang; Giselle P Lim; Takashi Morihara; Oliver J Ubeda; Surendra Ambegaokar; James E Hansen; Richard H Weisbart; Bruce Teter; Sally A Frautschy; Gregory M. Cole
Role of p21-activated kinase pathway defects in the cognitive deficits of Alzheimer disease.
Nature neuroscience 2006;9(2):234-42.
2006: Marc Morissette; Mehdi Dridi; Frederic Calon; Abdallah Hadj Tahar; Leonard T Meltzer; Paul J Bédard; Thérèse Di Paolo
Prevention of levodopa-induced dyskinesias by a selective NR1A/2B N-methyl-D-aspartate receptor antagonist in parkinsonian monkeys: implication of preproenkephalin.
Movement disorders : official journal of the Movement Disorder Society 2006;21(1):9-17.
2005: Frederic Calon; Giselle P Lim; Takashi Morihara; Fusheng Yang; Oliver J Ubeda; Norman Salem; Sally A Frautschy; Gregory M. Cole
Dietary n-3 polyunsaturated fatty acid depletion activates caspases and decreases NMDA receptors in the brain of a transgenic mouse model of Alzheimer's disease.
The European journal of neuroscience 2005;22(3):617-26.
2005: Giselle P Lim; Frederic Calon; Takashi Morihara; Fusheng Yang; Bruce Teter; Oliver J Ubeda; Norman Salem; Sally A Frautschy; Gregory M. Cole
A diet enriched with the omega-3 fatty acid docosahexaenoic acid reduces amyloid burden in an aged Alzheimer mouse model.
The Journal of neuroscience : the official journal of the Society for Neuroscience 2005;25(12):3032-40.
2004: Frederic Calon; Giselle P Lim; Fusheng Yang; Takashi Morihara; Bruce Teter; Oliver J Ubeda; Phillippe Rostaing; Antoine Triller; Norman Salem; Karen K. Hsiao Ashe; Sally A Frautschy; Gregory M. Cole
Docosahexaenoic acid protects from dendritic pathology in an Alzheimer's disease mouse model.
Neuron 2004;43(5):633-45.
2004: Pierre J Blanchet; Frederic Calon; Marc Morissette; Abdallah Hadj Tahar; Nancy Bélanger; Pershia Samadi; Richard Grondin; Laurent Grégoire; Leonard T Meltzer; Thérèse Di Paolo; Paul J Bédard
Relevance of the MPTP primate model in the study of dyskinesia priming mechanisms.
Parkinsonism & related disorders 2004;10(5):297-304.
2004: Frederic Calon; Mehdi Dridi; Oleh Hornykiewicz; Paul J Bédard; Ali H Rajput; Thérèse Di Paolo
Increased adenosine A2A receptors in the brain of Parkinson's disease patients with dyskinesias.
Brain : a journal of neurology 2004;127(Pt 5):1075-84.
2003: Frederic Calon; Ali H Rajput; Oleh Hornykiewicz; Paul J Bédard; Thérèse Di Paolo
Levodopa-induced motor complications are associated with alterations of glutamate receptors in Parkinson's disease.
Neurobiology of disease 2003;14(3):404-16.
2003: Frederic Calon; Marc Morissette; Ali H Rajput; Oleh Hornykiewicz; Paul J Bédard; Thérèse Di Paolo
Changes of GABA receptors and dopamine turnover in the postmortem brains of parkinsonians with levodopa-induced motor complications.
Movement disorders : official journal of the Movement Disorder Society 2003;18(3):241-53.
2003: Yun Zhang; Frederic Calon; Chunni Zhu; Ruben J Boado; William M Pardridge
Intravenous nonviral gene therapy causes normalization of striatal tyrosine hydroxylase and reversal of motor impairment in experimental parkinsonism.
Human gene therapy 2003;14(1):1-12.
2003: Abdallah Hadj Tahar; Richard Grondin; Laurent Grégoire; Frederic Calon; Thérèse Di Paolo; Paul J Bédard
New insights in Parkinson's disease therapy: can levodopa-induced dyskinesia ever be manageable.
Advances in neurology 2003;91():51-64.
2002: Frederic Calon; Thérèse Di Paolo
Levodopa response motor complications--GABA receptors and preproenkephalin expression in human brain.
Parkinsonism & related disorders 2002;8(6):449-54.
2002: Jean-Christophe Olivier; Ramon Huertas; Hwa Jeong Lee; Frederic Calon; William M Pardridge
Synthesis of pegylated immunonanoparticles.
Pharmaceutical research 2002;19(8):1137-43.
2002: Frederic Calon; Sam Birdi; Ali H Rajput; Oleh Hornykiewicz; Paul J Bédard; Thérèse Di Paolo
Increase of preproenkephalin mRNA levels in the putamen of Parkinson disease patients with levodopa-induced dyskinesias.
Journal of neuropathology and experimental neurology 2002;61(2):186-96.
2002: Frederic Calon; Marc Morissette; Othman Ghribi; Marlyne Goulet; Richard Grondin; Pierre J Blanchet; Paul J Bédard; Thérèse Di Paolo
Alteration of glutamate receptors in the striatum of dyskinetic 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated monkeys following dopamine agonist treatment.
Progress in neuro-psychopharmacology & biological psychiatry 2002;26(1):127-38.
2002: Michel Cyr; Frederic Calon; Marc Morissette; Thérèse Di Paolo
Estrogenic modulation of brain activity: implications for schizophrenia and Parkinson's disease.
Journal of psychiatry & neuroscience : JPN 2002;27(1):12-27.
2001: P K Tekumalla; Frederic Calon; Zia Rahman; Sam Birdi; Ali H Rajput; Oleh Hornykiewicz; Thérèse Di Paolo; Paul J Bédard; Eric J Nestler
Elevated levels of DeltaFosB and RGS9 in striatum in Parkinson's disease.
Biological psychiatry 2001;50(10):813-6.
2001: Frederic Calon; N Lavertu; A M Lemieux; Marc Morissette; Marlyne Goulet; Richard Grondin; Pierre J Blanchet; Paul J Bédard; Thérèse Di Paolo
Effect of MPTP-induced denervation on basal ganglia GABA(B) receptors: correlation with dopamine concentrations and dopamine transporter.
Synapse (New York, N.Y.) 2001;40(3):225-34.
2001: Pierre J Blanchet; Frederic Calon; Marc Morissette; Marlyne Goulet; Richard Grondin; Daniel Lévesque; Paul J Bédard; Thérèse Di Paolo
Regulation of dopamine receptors and motor behavior following pulsatile and continuous dopaminergic replacement strategies in the MPTP primate model.
Advances in neurology 2001;86():337-44.
2000: Frederic Calon; Abdallah Hadj Tahar; Pierre J Blanchet; Marc Morissette; Richard Grondin; Marlyne Goulet; JP Doucet; George S Robertson; E Nestler; Thérèse Di Paolo; Paul J Bédard
Dopamine-receptor stimulation: biobehavioral and biochemical consequences.
Trends in neurosciences 2000;23(10 Suppl):S92-100.
2000: M Cyr; Frederic Calon; Marc Morissette; M Grandbois; Thérèse Di Paolo; Sophie Callier
Drugs with estrogen-like potency and brain activity: potential therapeutic application for the CNS.
Current pharmaceutical design 2000;6(12):1287-312.
2000: Frederic Calon; Marc Morissette; Marlyne Goulet; Richard Grondin; Pierre J Blanchet; Paul J Bédard; Thérèse Di Paolo
125I-CGP 64213 binding to GABA(B) receptors in the brain of monkeys: effect of MPTP and dopaminomimetic treatments.
Experimental neurology 2000;163(1):191-9.
2000: Frederic Calon; Richard Grondin; Marc Morissette; Marlyne Goulet; Pierre J Blanchet; Thérèse Di Paolo; Paul J Bédard
Molecular basis of levodopa-induced dyskinesias.
Annals of neurology 2000;47(4 Suppl 1):S70-8.
1999: Frederic Calon; Marc Morissette; Marlyne Goulet; Richard Grondin; Pierre J Blanchet; Paul J Bédard; Thérèse Di Paolo
Chronic D1 and D2 dopaminomimetic treatment of MPTP-denervated monkeys: effects on basal ganglia GABA(A)/benzodiazepine receptor complex and GABA content.
Neurochemistry international 1999;35(1):81-91.
1999: Paul J Bédard; Pierre J Blanchet; Daniel Lévesque; J J Soghomonian; Richard Grondin; Marc Morissette; Marlyne Goulet; Frederic Calon; P Falardeau; B Gomez-Mancilla; JP Doucet; George S Robertson; T DiPaolo
Pathophysiology of L-dopa-induced dyskinesias.
Movement disorders : official journal of the Movement Disorder Society 1999;14 Suppl 1():4-8.
1997: Marc Morissette; Marlyne Goulet; J J Soghomonian; Pierre J Blanchet; Frederic Calon; Paul J Bédard; Thérèse Di Paolo
Preproenkephalin mRNA expression in the caudate-putamen of MPTP monkeys after chronic treatment with the D2 agonist U91356A in continuous or intermittent mode of administration: comparison with L-DOPA therapy.
Brain research. Molecular brain research 1997;49(1-2):55-62.
1997: Marlyne Goulet; Marc Morissette; Frederic Calon; Pierre J Blanchet; P Falardeau; Paul J Bédard; Thérèse Di Paolo
Continuous or pulsatile chronic D2 dopamine receptor agonist (U91356A) treatment of drug-naive 4-phenyl-1,2,3,6-tetrahydropyridine monkeys differentially regulates brain D1 and D2 receptor expression: in situ hybridization histochemical analysis.
Neuroscience 1997;79(2):497-507.
1996: Marc Morissette; Marlyne Goulet; Frederic Calon; P Falardeau; Pierre J Blanchet; Paul J Bédard; Thérèse Di Paolo
Changes of D1 and D2 dopamine receptor mRNA in the brains of monkeys lesioned with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: correction with chronic administration of L-3,4-dihydroxyphenylalanine.
Molecular pharmacology 1996;50(5):1073-9.
1995: Frederic Calon; Marlyne Goulet; Pierre J Blanchet; J C Martel; M F Piercey; Paul J Bédard; Thérèse Di Paolo
Levodopa or D2 agonist induced dyskinesia in MPTP monkeys: correlation with changes in dopamine and GABAA receptors in the striatopallidal complex.
Brain research 1995;680(1-2):43-52.
1995: Pierre J Blanchet; Frederic Calon; J C Martel; Paul J Bédard; Thérèse Di Paolo; R R Walters; M F Piercey
Continuous administration decreases and pulsatile administration increases behavioral sensitivity to a novel dopamine D2 agonist (U-91356A) in MPTP-exposed monkeys.
The Journal of pharmacology and experimental therapeutics 1995;272(2):854-9.